February 26, 2020 / 12:48 PM / in a month

BRIEF-Kiniksa Pharmaceuticals Posts Qtrly Loss Per Share Of $0.58

Feb 26 (Reuters) - Kiniksa Pharmaceuticals Ltd:

* KINIKSA REPORTS FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS AND HIGHLIGHTS RECENT PIPELINE ACTIVITY

* QTRLY LOSS PER SHARE $0.58

* Q4 EARNINGS PER SHARE VIEW $-0.62 — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below